Shaunak Navalkissoor

The Impact of ⁶⁸ Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom

Evangelia Skoura, Sofia Michopoulou, Mullan Mohmaduvesh et al. · Journal of Nuclear Medicine · 2015 · 154 citations · Full text

Medicine, Oncology, Radiology +17

Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score

David Chan, Aimee R. Hayes, Ioannis Karfis et al. · British Journal of Cancer · 2022 · 88 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Peptide Receptor Radionuclide Treatment and (131)I‐MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas

Constantinos Nastos, Vincent Cheung, Christos Toumpanakis et al. · Journal of Surgical Oncology · 2017 · 78 citations · Full text

Medicine, Nuclear Medicine, Oncology +7

Capecitabine and streptozocin±cisplatin in advanced gastroenteropancreatic neuroendocrine tumours

Tim Meyer, Wendi Qian, Martyn Caplin et al. · European Journal of Cancer · 2014 · 70 citations

Medicine, Oncology, Cancer Pharmacology +11

Is hybrid imaging (SPECT/CT) a useful adjunct in the management of suspected facet joints arthropathy?

Hosam E. Matar, Shaunak Navalkissoor, Marko Berovic et al. · International Orthopaedics · 2013 · 69 citations

Medicine, Orthopaedic Surgery, Radiology +14